Peptide Capsules
GLOW Blend Capsules
GLOW capsules, clearly measured. 2 mg GHK-Cu, 500 mcg BPC-157 and 500 mcg TB-500 in every capsule, 60 capsules per bottle.
✓ In stock and ready to ship
Certificate of analysis View available reports and lot details
Product identification & intended use
SKU: SC-CAPS-GlowBlend-3000MCG
For laboratory research use only. Not for human or veterinary use.
Description
These capsules carry the GLOW research blend, GHK-Cu, BPC-157 and TB-500, in a pre-measured oral format. Each capsule holds 2 mg GHK-Cu, 500 mcg BPC-157 and 500 mcg TB-500, with 60 capsules per bottle. Available analytical documentation is listed in the COA library.
Chemical identity & storage
| Compound / component | CAS number | Molecular weight | Specification status |
|---|---|---|---|
| GHK-Cu (copper peptide) | 49557-75-7 | 403.9 g/mol Formula: C14H24N6O4Cu |
Catalog reference specification |
| BPC-157 | 137525-51-0 | 1419.5 g/mol Formula: C62H98N16O22 |
Catalog reference specification |
| TB-4 fragment (Ac-LKKTETQ) | 885340-08-9 | 889.02 g/mol Formula: C38H68N10O14 |
Formulation-specific label specification for capsules, sprays, GLOW and KLOW. |
Blend values are listed component by component; no mixture CAS number or mixture molecular weight is assigned.
Storage: Store tightly closed in a cool, dry place at controlled room temperature (15–25°C), protected from heat, light and moisture.
How the capsules differ from the vial.
The three compounds match the 70 mg GLOW vial, but the ratio is set for fixed oral units: 4 : 1 : 1 instead of 5 : 1 : 1. GHK-Cu is still the largest share, with BPC-157 and TB-500 in equal smaller amounts.
They suit oral-model research where reconstituting and dividing a vial would add steps you don’t need.
At a glance.
| GHK-Cu | 2 mg per capsule |
|---|---|
| BPC-157 | 500 mcg per capsule |
| TB-500 | 500 mcg per capsule |
| Total per capsule | 3 mg |
| Ratio | 4 : 1 : 1 (GHK-Cu : BPC-157 : TB-500) |
| Count | 60 capsules |
| Catalog reference | SBL-8273 |
The three components.
GHK-Cu is a copper-binding tripeptide known from collagen and gene-expression work in skin and connective tissue. BPC-157 is a gastric-protein fragment with a record of oral-route rodent studies. TB-500 is a thymosin beta-4-based peptide studied in cell-migration and repair models. The evidence for each is preclinical, and the blend has not been studied clinically.
Other formats.
For four peptides with KPV added, see the KLOW blend. For single-compound capsules, see GHK-Cu, BPC-157 and TB-500.
Documentation.
Available analytical documentation is organized by compound, strength and format in the COA library. Do not treat a report as lot-specific unless a documented lot match is shown.
Handling.
The capsules come pre-measured in a sealed bottle, so there is nothing to reconstitute. Keep the bottle tightly closed somewhere cool and dry, away from heat, humidity and direct light.
Questions.
What is in each capsule?
2 mg GHK-Cu, 500 mcg BPC-157 and 500 mcg TB-500.
Is the ratio the same as the vial?
No. The vial is 5 : 1 : 1 (50, 10 and 10 mg). The capsule is 4 : 1 : 1 (2 mg, 500 mcg and 500 mcg).
Is this a supplement?
No. It is sold strictly as laboratory research material.
Further reading.
KLOW vs GLOW: how the two blends differ
For laboratory research use only. Not for human or veterinary use.
